HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages

Immunologic Research

Volumn 27, Issue 2-3, 2003, Pages 261-276

  Freedman, Bruce D ^a,c   Liu, Qing Hua ^a   Del Corno, Manuela ^b   Collman, Ronald G ^b  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AIDS; Calcium; CCR5; CXCR4; Ion channels; Pyk 2

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; ION CHANNEL; VIRUS ENVELOPE PROTEIN;

CELL ACTIVATION; CELL FUNCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; VIRUS ENVELOPE; VIRUS REPLICATION;

HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MACROPHAGES; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 0141680212     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:27:2-3:261     Document Type: Review

References (85)

1. Gendelman HE, Meltzer MS: Mononuclear phagocytes and the human immunodeficiency virus. Curr Opin Immunol 1989;2:414-419.
2. Collman R: Human immunodeficiency virus type 1 tropism for human macrophages. Pathobiology 1992;60:213-218.
3. Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS: Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 1992;66:2217-2225.
4. Shiratsuchi H., Johnson JL, Toossi Z, Ellner JJ: Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120. J Clin Invest 1994;93:885-891.
5. Borghi P, Fantuzzi L, Varano B, et al.: Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol 1995;69:1284-1287.
6. Koziel H, Eichbaum Q, Kruskal BA, et al.: Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 1998;102:1332-1344.
7. Wahl SM, Allen JB, Gartner S, et al.: HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol 1989;142:3553-3559.
8. Herbein G., Keshav S, Collin M, Montaner LJ, Gordon S: HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection. Clin Exp Immunol 1994;95:442-449.
9. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL: Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 1989;86:621-625.
10. Kolson DL, Lavi E, Gonzalez-Scarano F: The effects of human immunodeficiency virus in thecentral nervous system. Adv Virus Res 1998;50:1-47.
11. Lipton SA Gendelman HE: Seminars in medicine of the Beth Israel Hospital. Boston. Dementia associated with the acquired immunodeficiency syndrome [see comments]. N Engl J Med 1995;332:934-940.
12. Crowe SM: Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection. Aust N Z J Med 1995;25:777-783.
13. Bukrinsky MI, Nottet HS, Schmidtmayerova H, et al.: Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995;181:735-745.
14. Gelbard HA, Nottet HS, Swindells S, et al.: Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994;68:4628-4635.
15. Grant RS, Naif H, Thuruthyil SJ, Nasr N, Littlejohn T, Takikawa O, Kapoor V: Induction of indolamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent. J Virol 2000;74:4110-4115.
16. Rucker J, Doms RW: Chemokine receptors as HIV coreceptors: implications and interactions. AIDS Res Hum Retroviruses 1998;14:S241-S246.
17. Berger EA, Murphy PM, Farber JM: Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700.
18. Yi Y, Rana S, Turner JD, Gaddis N, Collman RG: CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:772-777.
19. Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW: Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci USA 1999;96:5215-5220.
20. Simmons G, Reeves JD, McKnight A, et al.: CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 1998;72:8453-8457.
21. Yi Y, Isaacs SN, Williams DA, et al.: Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV- 1) strains: two distinct mechanisms of HIV-1 dual tropism. J Virol 1999;73:7117-7125.
22. Edinger AL, Amedee A, Miller K, et al.: Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci USA 1997;94:4005-4010.
23. Kirchhoff F, Pohlmann S, Hamacher M, et al.: Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx 174 cells for efficient entry. J Virol 1997;71:6509-6516.
24. Chen Z, Zhou P, Ho DD, Landau NR, Marx PA: Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997;71:2705-2714.
25. Mori K, Ringler DJ, Desrosiers RC: Restricted replication of simian immunodeficiency virus strain 239 in macrophagesis determined by Env but is not due to restricted entry. J Virol 1993;67:2807-2814.
26. Chackerian B, Long EM, Luciw PA, Overbaugh J: Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 1997;71:3932-3939.
27. Arthos J, Rubbert A, Rabin RL, et al.: CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J Virol 2000;74:6418-6424.
28. Horuk R: Chemokine receptors and HIV-1: the fusion of two major research fields. Immunol Today 1999;20:89-94.
29. Locati M, Murphy PM: Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu Rev Med 1999:50:425-440.
30. Hamm HE: The many faces of G protein signaling. J Biol Chem 1998;273:669-672.
31. Bacon KB: Analysis of signal transduction following lymphocyte activation by chemokines. Methods Enzymol 1997;288:340-361.
32. Kuang Y, Wu Y, Smrcka A, Jiang H, Wu D: Identification of a phospholipase C β2 region that interacts with Gbeta-gamma. Proc Natl Acad Sci USA 1996;93:2964-2968.
33. Jan LY, Jan YN: Receptor-regulated ion channels. Curr Opin Cell Biol 1997;9:155-160.
34. Gosling J, Monteclaro FS, Atchison RE, Arai H, Tsou CL, Goldsmith MA, Charo IF: Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc Natl Acad Sci USA 1997;94:5061-5066.
35. Ford CE, Skiba NP, Bae H, et al.: Molecular basis for interactions of G protein βγ subunits with effectors. Science 1998;280:1271-1274.
36. Brown AM, Birnbaumer L: Ionic channels and their regulation by G protein subunits. Annu Rev Physiol 1990;52:197-213.
37. Wickman K, Clapham DE: Ion channel regulation by G proteins. Physiol Rev 1995;75:865-885.
38. Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390:88-91.
39. Arai H, Tsou CL, Charo IF: Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Gαi-coupled receptors. Proc Natl Acad Sci USA 1997;94:14,495-14,499.
40. Kuang Y., Wu Y, Jiang H, Wu D: Selective G protein coupling by C-C chemokine receptors. J Biol Chem 1996;271:3975-3978.
41. Weissman D, Rabin RL, Arthos J, et al.: Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 1997;389:981-985.
42. Davis CB, Dikic I, Unutmaz D, et al.: Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997;186:1793-1798.
43. Liu QH, Williams DA, McManus C, et al.: HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc Natl Acad Sci USA 2000;97:4832-4837.
44. Cicala C, Arthos J, Rubbert A, Selig S, Wildt K, Cohen OJ, Fauci AS: HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. Proc Natl Acad Sci USA 2000;97:1178-1183.
45. Ganju RK, Brubaker SA, Chernock RD, Avraham S, Groopman JE: Beta chemokine receptor CCR5 signals through SHP1 SHP2 and Syk. J Biol Chem 2000.
46. Popik W, Hesselgesser JE, Pitha PM: Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol 1998;72:6406-6413.
47. Popik W, Pitha PM: Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor. Virology 1998;252:210-217.
48. Dairaghi DJ, Soo KS, Oldham ER, Premack BA, Kitamura T, Bacon KB, Schall TJ: RANTES-induced T cell activation correlates with CD3 expression. J Immunol 1998;160:426-433.
49. Lev S, Moreno H, Martinez R, et al.: Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 1995;376:737-745.
50. Zhao J, Ma L, Wu YL, Wang P, Hu W, Pei G: Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J Cell Biochem 1998;71:36-45.
51. Vicente-Manzanares M, Rey M, Jones DR, et al.: Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis. J Immunol 1999;163:4001-4012.
52. Sotsios Y, Whittaker GC, Westwick J, Ward SG: The CXC Chemokine Stromal Cell-Derived Factor Activates a Gi-Coupled Phosphoinositide 3-Kinase in T Lymphocytes. J Immunol 1999;163:5954-5963.
53. Gallin EK: Ion channels in Leukocytes. Physiol Rev 1991;71:775-811.
54. Eder C: Ion channels in microglia (brain macrophages). Am J Physiol 1998;275:C327-C342.
55. DeCoursey TE, Cherny VV: Voltage-activated proton currents in human THP-1 monocytes. J Membr Biol 1996;152:131-140.
56. Nelson DJ, Jacobs ER, Tang JM, Zeller JM, Bone RC: Immunoglobulin G-induced single ionic channels in human alveolar macrophage membranes. J Clin Invest 1985;76:500-507.
57. Ince C., Coremans JM, Ypey DL, Leijh PC, Verveen AA, Van Furth R: Phagocytosis by human macrophages is accompanied by changes in ionic channel currents. J Cell Biol 1988;106:1873-1878.
58. Brown H., Kozlowski R, Perry H: The importance of ion channels for macrophage and microglial activation in vitro. Glia 1998;22:94-97.
59. Chiozzi P, Sanz JM, Ferrari D, et al.: Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J Cell Biol 1997;138:697-706.
60. Ferrari DF, Chiozzi P, Falzoni S, Susino MD, Melchiorri L, Baricordi OR, Di Virgilio F: Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J Immunol 1997;159:1451-1458.
61. Denlinger LC, Fisette PL, Garis KA, et al.: Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 1996;271:337-342.
62. Raddassi K., Berthon B, Petit JF, Lemaire G: Role of calcium in the activation of mouse peritoneal macrophages: induction of NO synthase by calcium ionophores and thapsigargin. Cell Immunol 1994;153:443-455.
63. Watanabe N, Suzuki J, Kobayashi Y: Role of calcium in tumor necrosis factor-alpha production by activated macrophages. J Biochem (Tokyo) 1996;120:1190-1195.
64. Lee B, Sharron M, Blanpain C, et al.: Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem 1999;274:9617-9626.
65. Iyengar S, Hildreth JE, Schwartz DH: Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J Virol 1998;72:5251-5255.
66. Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, Broder CC: A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology 1999;259:1-6.
67. Lapham CK, Zaitseva MB, Lee S, Romanstseva T, Golding H: Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nat Med 1999;5:303-308.
68. Roullet E: Opportunistic infections of the central nervous system during HIV-1 infection (emphasis on cytomegalovirus disease). J Neurol 1999;246:237-243.
69. Fenton MJ: Macrophages and tuberculosis. Curr Opin Hematol 1998;5:72-78.
70. Chaturvedi S, Newman SL: Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120. J Clin Invest 1997;100:1465-1474.
71. Pietrella D, Monari C, Retini C, Palazzetti B, Bistoni F, Vecchiarelli A: Human immunodeficiency virus type 1 envelope protein gp120 impairs intracellular antifungal mechanisms in human monocytes. J Infect Dis 1998;177:347-354.
72. Crowe SM, Vardaxis NJ, Kent SJ, Maerz AL, Hewish MJ, McGrath MS, Mills J: HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol 1994;56:318-327.
73. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990;141:471-501.
74. Koka P, He K, Zack JA, et al.: Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995;182:941-951.
75. Agostini C, Sancetta R, Cerutti A, Semenzato G: Alveolar macrophages as a cell source of cytokine hyperproduction in HIV-related interstitial lung disease. J Leukoc Biol 1995;58:495-500.
76. Agostini C, Zambello R, Trentin L, et al.: Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha. Am Rev Respir Dis 1991;144:195-201.
77. + cells in the lung. Am J Respir Cell Mol Biol 1989;1:391-400.
78. Gessani S, Puddu P, Varano B, Borghi P, Conti L, Fantuzzi L, Belardelli F: Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of β-interferon in restriction of virus replication. J Virol 1994;68:1983-1986.
79. Capobianchi MR, Barresi C, Borghi P, et al.: Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8. J Virol 1997;71:1591-1597.
80. Moorjani H., Craddock BP, Morrison SA, Steigbigel RT: Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages. J Acquit Immune Defic Syndr Hum Retrovirol 1996;13:18-22.
81. Nottet HS, Jett M, Flanagan CR, et al.: A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 1995;154:3567-3581.
82. + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 1998;395:189-194.
83. Smyth RJ, Yi Y, Singh A, Collman RG: Determinants of entry cofactor utilization and tropism in a dual-tropic human immunodeficiency virus type 1 primary isolate. J Virol 1998;72:4478-4484.
84. Guntermann C, Murphy BJ, Zheng R, Qureshi A, Eagles PA, Nye KE: Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP down-regulation. Biochem Biophys Res Commun 1999;256:429-435.
85. Alfano M, Schmidtmayerova H, Amelia CA, Pushkarsky T, Bukrinsky M: The β-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. J Exp Med 1999;190:597-605.